These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2864615)

  • 1. Systemic complications of intravesical BCG therapy for bladder cancer.
    Steg A; Sicard D; Leleu C; Debré B; Boccon-Gibod L
    Lancet; 1985 Oct; 2(8460):899. PubMed ID: 2864615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder].
    Gargot D; Alexandre L; Sinico M; Salmeron S; Benoit G; Buffet C
    Gastroenterol Clin Biol; 1991; 15(8-9):662-3. PubMed ID: 1752384
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of superficial bladder tumors with intravesical BCG vaccine].
    Damianov Kh; Engibarov A; Patrashkov T; Tonchev T; Chuchkova M
    Khirurgiia (Sofiia); 1988; 41(2):23-8. PubMed ID: 3411877
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder.
    Xerri B; Chrétien Y; Le Parc JM
    Eur J Med; 1993; 2(8):503-5. PubMed ID: 8258055
    [No Abstract]   [Full Text] [Related]  

  • 7. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J; Stein B
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal complications of intravesical bacillus Calmette-Guérin therapy.
    Modesto A; Marty L; Suc JM; Kleinknecht D; de Frémont JF; Marsepoil T; Veyssier P
    Am J Nephrol; 1991; 11(6):501-4. PubMed ID: 1819218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pitfalls in intravesical immunotherapy of superficial carcinoma of the gallbladder with BCG vaccine].
    Pacík D; Vít V; Turjanica M
    Rozhl Chir; 1997 Jan; 76(1):3-5. PubMed ID: 9182342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal cure].
    Truniger B
    Schweiz Med Wochenschr; 1999 May; 129(19):748. PubMed ID: 10407950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].
    Sai S; Sakakibara T; Takashi M; Sakata T; Miyake K
    Hinyokika Kiyo; 1990 Aug; 36(8):953-5. PubMed ID: 2239600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reiter's syndrome after intravesical Bacillus Calmette-Guérin therapy for bladder cancer.
    Hodish I; Ezra D; Gur H; Strugo R; Olchovsky D
    Isr Med Assoc J; 2000 Mar; 2(3):240-1. PubMed ID: 10774277
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesical Bacillus Calmette-Guerin therapy. Effective immunotherapy against bladder cancer].
    Damm O
    Lakartidningen; 1994 Mar; 91(10):939-40. PubMed ID: 8139314
    [No Abstract]   [Full Text] [Related]  

  • 16. ["BCGitis", a systemic complication of intravesical BCG therapy of bladder tumor].
    Sicard D; Steg A; Leleu C; Boccaccio F; Abadia R; Tulliez M; Cremer GA
    Ann Med Interne (Paris); 1987; 138(7):555-6. PubMed ID: 3439677
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A; Belas M; Leleu C; Boccon-Gibod L
    Prog Clin Biol Res; 1989; 310():153-60. PubMed ID: 2771990
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic hypersensitivity reaction to intravesical BCG.
    Lyons D; Miller I; Jeffers A
    Scott Med J; 1994 Apr; 39(2):49-50. PubMed ID: 8720760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
    Aso Y; Akaza H; Kameyama S; Niijima T
    Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary disease following intravesical BCG treatment.
    Kesten S; Title L; Mullen B; Grossman R
    Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.